X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (149) 149
child (107) 107
hematology (91) 91
risk factors (86) 86
female (84) 84
adolescent (72) 72
child, preschool (72) 72
male (72) 72
index medicus (70) 70
infant (70) 70
children (63) 63
infant, newborn (60) 60
peripheral vascular disease (55) 55
thrombosis (38) 38
mutation (33) 33
pediatrics (31) 31
thromboembolism (30) 30
thrombophilia (30) 30
adult (28) 28
factor v - genetics (28) 28
cohort studies (26) 26
childhood (24) 24
risk-factors (24) 24
factor-v-leiden (23) 23
thrombophilia - genetics (22) 22
stroke (21) 21
prospective studies (20) 20
prothrombin - genetics (20) 20
case-control studies (19) 19
recurrence (18) 18
infants (17) 17
protein c (17) 17
activated protein-c (16) 16
therapy (16) 16
arterial ischemic-stroke (15) 15
lipoprotein - blood (15) 15
methylenetetrahydrofolate reductase (15) 15
thromboembolism - genetics (15) 15
thrombophilia - complications (15) 15
abridged index medicus (14) 14
age factors (14) 14
anticoagulants - therapeutic use (14) 14
clinical neurology (14) 14
inherited thrombophilia (14) 14
point mutation (14) 14
risk (14) 14
thrombophilia - epidemiology (14) 14
treatment outcome (14) 14
analysis (13) 13
follow-up studies (13) 13
genetic predisposition to disease (13) 13
health aspects (13) 13
hemostasis (13) 13
lipoprotein (13) 13
middle aged (13) 13
prevalence (13) 13
thromboembolism - blood (13) 13
venous thrombosis (13) 13
young adult (13) 13
complications (12) 12
hemophilia (12) 12
prothrombotic risk-factors (12) 12
coagulation (11) 11
metaanalysis (11) 11
multivariate analysis (11) 11
plasma (11) 11
postthrombotic syndrome (11) 11
pregnancy (11) 11
prothrombotic risk factors (11) 11
stroke - genetics (11) 11
thromboembolism - diagnosis (11) 11
thromboembolism - epidemiology (11) 11
thromboembolism - etiology (11) 11
thrombophilia - blood (11) 11
venous thromboembolism (11) 11
cerebral sinovenous thrombosis (10) 10
disease (10) 10
genotype (10) 10
germany - epidemiology (10) 10
heterozygote (10) 10
odds ratio (10) 10
oxidoreductases acting on ch-nh group donors - genetics (10) 10
venous thrombosis - epidemiology (10) 10
fibrinolytic agents - therapeutic use (9) 9
further section (9) 9
molecular-weight heparin (9) 9
stroke - blood (9) 9
stroke - epidemiology (9) 9
thrombophilia - diagnosis (9) 9
thrombosis - blood (9) 9
thrombosis - etiology (9) 9
venous thrombosis - blood (9) 9
acute lymphoblastic-leukemia (8) 8
aged (8) 8
antithrombin-iii (8) 8
fibrinolysis (8) 8
hematology, oncology and palliative medicine (8) 8
hemophilia a - genetics (8) 8
protein c deficiency (8) 8
retrospective studies (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e737S - e801S
Background: Neonates and children differ from adults in physiology, pharmacologic responses to drugs, epidemiology, and long-term consequences of thrombosis.... 
INFERIOR VENA-CAVA | TISSUE-PLASMINOGEN-ACTIVATOR | ARTERIAL ISCHEMIC-STROKE | RESPIRATORY SYSTEM | CEREBRAL SINOVENOUS THROMBOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | HEPARIN-INDUCED THROMBOCYTOPENIA | SICKLE-CELL-DISEASE | HOMOZYGOUS PROTEIN-C | CRITICAL CARE MEDICINE | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Upper Extremity Deep Vein Thrombosis - blood | Child, Preschool | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Upper Extremity Deep Vein Thrombosis - prevention & control | Hemorrhage - prevention & control | Secondary Prevention | Heparin - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Cardiac Catheterization | Vitamin K - antagonists & inhibitors | Societies, Medical | Platelet Aggregation Inhibitors - administration & dosage | Renal Veins | Thrombosis - blood | Thrombosis - prevention & control | Child | Infant, Newborn | Platelet Aggregation Inhibitors - adverse effects | Upper Extremity Deep Vein Thrombosis - drug therapy | Drug Administration Schedule | Risk Factors | Cooperative Behavior | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Interdisciplinary Communication | Thrombosis - etiology | Blood Coagulation Tests | Fibrinolytic Agents - administration & dosage | Thrombosis - drug therapy | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Circulation, ISSN 0009-7322, 2010, Volume 121, Issue 16, pp. 1838 - 1847
Journal Article
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 11/2002, Volume 360, Issue 9345, pp. 1540 - 1545
Journal Article
Journal Article